OBJECTIVE: To compare detection of respiratory syncytial virus (RSV) for diagnostic purposes using nasopharyngeal aspirate (NPA) and nasal swabs (NS) in different clinical settings in a community study in Guinea-Bissau. METHOD: During 1996-98 paired specimens were obtained from 635 children under 5 years of age (median: 274 days; interquartile range: 144-453 days) with symptoms of lower respiratory infections (LRI). The specimens were analysed by an enzyme-linked immunosorbent assay for RSV antigen in Guinea-Bissau and re-analysed in Denmark using the same assay. The gold standard for RSV antigen detection was defined as any test being positive. RESULTS: RSV antigen was detected in 84 (13%) children, the prevalence being 19% (41/219) among infants aged < 6 months, 12% (22/184) in infants aged 6-11 months, and 9% (21/230) in older children. Sensitivity of antigen detection was higher in NPA (92% in analyses in Guinea-Bissau and 98% in Denmark) than in NS (63% in analyses in Guinea-Bissau, 71% in Denmark). Specificity of RSV antigen detection was equally high in NPA and NS (99-100%). Time since onset of symptoms was significantly shorter in RSV antigen positive than negative samples. Sensitivity did not depend on clinical setting or age of the child. CONCLUSION: Using NS samples was associated with a 27-31% reduction in sensitivity compared with NPA specimens. As NPAs are costly and considered a nuisance by the population, it might be cost-effective in larger epidemiological studies to lose 25-30% in sensitivity but be able to collect samples from a much larger population.
OBJECTIVE: To compare detection of respiratory syncytial virus (RSV) for diagnostic purposes using nasopharyngeal aspirate (NPA) and nasal swabs (NS) in different clinical settings in a community study in Guinea-Bissau. METHOD: During 1996-98 paired specimens were obtained from 635 children under 5 years of age (median: 274 days; interquartile range: 144-453 days) with symptoms of lower respiratory infections (LRI). The specimens were analysed by an enzyme-linked immunosorbent assay for RSV antigen in Guinea-Bissau and re-analysed in Denmark using the same assay. The gold standard for RSV antigen detection was defined as any test being positive. RESULTS:RSV antigen was detected in 84 (13%) children, the prevalence being 19% (41/219) among infants aged < 6 months, 12% (22/184) in infants aged 6-11 months, and 9% (21/230) in older children. Sensitivity of antigen detection was higher in NPA (92% in analyses in Guinea-Bissau and 98% in Denmark) than in NS (63% in analyses in Guinea-Bissau, 71% in Denmark). Specificity of RSV antigen detection was equally high in NPA and NS (99-100%). Time since onset of symptoms was significantly shorter in RSV antigen positive than negative samples. Sensitivity did not depend on clinical setting or age of the child. CONCLUSION: Using NS samples was associated with a 27-31% reduction in sensitivity compared with NPA specimens. As NPAs are costly and considered a nuisance by the population, it might be cost-effective in larger epidemiological studies to lose 25-30% in sensitivity but be able to collect samples from a much larger population.
Authors: Rita Y T Sung; Paul K S Chan; Kai C Choi; Apple C M Yeung; Albert M Li; Julian W Tang; Margaret Ip; Tracy Tsen; E Anthony S Nelson Journal: J Clin Microbiol Date: 2008-07-09 Impact factor: 5.948
Authors: Iona Munjal; Philip Gialanella; Cheryl Goss; John C McKitrick; Jeffrey R Avner; Qiulu Pan; Nathan Litman; Michael H Levi Journal: J Clin Microbiol Date: 2010-12-22 Impact factor: 5.948
Authors: T J Meerhoff; M L Houben; F E J Coenjaerts; J L L Kimpen; R W Hofland; F Schellevis; L J Bont Journal: Eur J Clin Microbiol Infect Dis Date: 2010-01-29 Impact factor: 3.267
Authors: Anh Ha Lien Do; H Rogier van Doorn; My Ngoc Nghiem; Juliet E Bryant; Thanh Hang thi Hoang; Quang Ha Do; Tan Le Van; Tan Thanh Tran; Bridget Wills; Vinh Chau van Nguyen; Minh Hien Vo; Cong Khanh Vo; Minh Dung Nguyen; Jeremy Farrar; Tinh Hien Tran; Menno D de Jong Journal: PLoS One Date: 2011-03-24 Impact factor: 3.240
Authors: Hirono Otomaru; Johanna Beulah T Sornillo; Taro Kamigaki; Samantha Louise P Bado; Michiko Okamoto; Mariko Saito-Obata; Marianette T Inobaya; Edelwisa Segubre-Mercado; Portia P Alday; Mayuko Saito; Veronica L Tallo; Beatriz P Quiambao; Hitoshi Oshitani; Alex R Cook Journal: Am J Epidemiol Date: 2021-12-01 Impact factor: 4.897
Authors: Maria Mathisen; Tor A Strand; Biswa N Sharma; Ram K Chandyo; Palle Valentiner-Branth; Sudha Basnet; Ramesh K Adhikari; Dag Hvidsten; Prakash S Shrestha; Halvor Sommerfelt Journal: BMC Med Date: 2009-07-27 Impact factor: 8.775